Scios, a Johnson & Johnson subsidiary, pled guilty on Thursday for falsely marketing Natrecor, a heart failure drug, according to recent news sources.
Scios was charged with a misdemeanor violation of the Food, Drug and Cosmetic Act. The U.S. has also sued Scios in a related case under the False Claims Act in California. Scios will pay a criminal fine of $85 million.
Natrecor was approved by the Food and Drug Administration in 2001 for those with acutely decompensated congestive heart failure who experience shortness of breath when at rest or at minimal activity.
Scios has admitted having the intention of also using the drug for chronic (non-acute) instances of congestive heart failure, which was not approved by the FDA.
As a Los Angeles personal injury lawyer, I urge anyone taking medication to be extremely careful. If you or someone you care about has been injured by a drug and the side effects of that drug, or feel the side effects were not made clear, or believe that the drug was falsely marketed, it is in your best interest to speak with a personal injury attorney as soon as possible in order to discuss the legal options that are available to you or your loved one.
Johnson & Johnson is conducting yet another recall, this time of its Eprex anemia drug, due to a lack of potency, according to recent news sources.
The recall affects about 200,000 syringes of the Eprex anemia drug. The drug is sold at the wholesale and pharmacy level. Johnson & Johnson believes most of the product has already been consumed, leaving about 6,300 syringes on the market. Seventeen different countries are affected by the recall, including the U.K. and Canada. The United States is not among the countries affected.
No illnesses or injuries have currently been reported in regards to the drug, according to Johnson & Johnson.
This year, Johnson & Johnson seems to be announcing one recall after another, with an expected loss of sales totaling about $900 million.
As a product defect lawyer in Los Angeles, I hope that no one’s health is adversely affected by consuming this drug. In my experience as a product liability lawyer, I know that altered drugs or drugs that have been tampered with can lead to serious long-term suffering. If you have been injured by a drug, I advise you to contact a personal injury lawyer to protect your rights and discuss your legal options.
A negative review from the Food and Drug Administration recommends against Xarelto, an anti blood clotting drug used to prevent strokes in those with atrial fibrillation, according to news sources.
Atrial fibrillantion is a heart-rhythm disorder that increases one’s chance of a stroke. According to the staff review of the drug released by Bayer and Johnson & Johnson, there was “a lack of substantial evidence that [the drug] will have its desired effect when used as recommended. The review also did not feel the drug was proven safe, and listed bleeding as a concern.
The panel of medical experts will further review the product for long-term use in these patients and release its recommendation by November. The drug is currently approved to be used as a short-term solution for blood clots of those undergoing knee or hip-replacement surgery. The staff has considered approving the drug for second or third choice of treatment.
As a product liability lawyer, drug safety and keeping people informed of potential dangers of medical products is a big priority for me. I would like you to know that our Los Angeles personal injury lawyers are here to help you and your loved ones if anything ever does happen because of a medical product. Do not hesitate to call use right away if this medicine or any other consumer product has caused you pain and suffering and please come back to our blog regularly so that you are informed about new dangerous consumer products.
A Johnson & Johnson CEO paid more than any other pharmaceutical company CEO may be forced to pay back a large amount of that compensation in a recent shareholder lawsuit, according to news reports.
The CEO in question has been paid more than $150 million since 2006. Shareholders argue that this is “lavish and excessive” because it’s more than the following four drug company CEOs combined, and Johnson & Johnson’s stock, operating cash flow, and revenues have stayed flat while its R&D declined and liabilities increased. These liabilities include 26 product recalls, most notably the recall of 93,000 artifical hips after they were implanted in consumers.
The plaintiffs have found fault with Johnson & Johnson’s compensation policy, which they have stated is not based just on results “but also for the manner in which they achieve them.” They argue that the board has continued to unfairly compensate the CEO even though he repeatedly violated the Johnson & Johnson credo, which the compensation policy is based upon.
Johnson & Johnson has not yet filed a response.
As a Los Angeles personal injury lawyer, consumer safety and holding companies accountable for their products is of the utmost importance to me. If you or a loved one has been injured because of hazardous medical product I suggest you seek medical attention right away. It can also be just as important to contact a product defect lawyer as soon as possible because you may be entitled to monetary compensation as a result of getting injured because of a defective or recalled product. You should also remember that the longer you take to contact someone about your case the more chance you have to lose evidence.
Johnson & Johnson announced Monday that it is recalling over two million packages of over-the-counter Tylenol brand cold medicine due to an excessive amount of a chemical compound found in the drug, report news sources
Subject to recall are almost 2.5 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps. The cold relief medicine is being pulled from both retail shelves and wholesaler stock because of the discovery in some capsules of slightly higher-than-expected levels of chlorpheniramine ammonio acetate (CPAA). The health care giant says the recall does affect any drug that consumers may already have in their homes.
CPAA, formed by combining two product ingredients, has not been associated with any health complaints.
The recalled medicine was produced at production facilities operated by beleaguered McNeil Consumer Healthcare, which has been at the heart of several J&J drug recalls, including actions involving Tylenol brand products, Benadryl and Sudafed brand products, and prescription drugs Risperdal and Prezista. Product recalls have cost J&J about $900 million in sales over the last year.
I hope this latest J&J recall does not negatively impact consumers.
As a Los Angeles personal injury lawyer, I encourage consumers to stay safe by practicing good medicine cabinet maintenance habits like clearing out expired medicines and prescriptions and staying aware of potential negative drug interactions.